Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shih-Duo Hsu Hung
Institutions:
Institute of Biomedical Sciences, Academia Sinica,
Academia Sinica
Observed institutions:
Institute of Biomedical Sciences, Academia Sinica,
Academia Sinica
ORCID:
0009-0001-4225-1583
Observed ORCID:
0009-0001-4225-1583
OpenAlex ID:
A5066412972
Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
·
Cancer Research
·
46
PDF
Regulation of PD-L1 glycosylation and advances in cancer immunotherapy
2025
·
Te-An Lee
, En-Yun Tsai
, et al.
·
Cancer Letters
·
33
CARTelligence Guides AI Optimization of gPD-L1 CAR-T Cells (Analysis of single-cell scFv Repertoire sequencing)
2026
·
Shih-Han Wang
, Chun-Tse Kuo
, et al.
·
Code Ocean
Blood-based biomarkers associated with long COVID: an updated systematic review
2026
·
Yun-Ju Lai
, Te-An Lee
, et al.
·
BMC Infectious Diseases
Smyca-FOXM1 ribonucleoprotein complex promotes homologous recombination and tumor immune evasion to define a therapeutic target of triple-negative breast cancer
2026
·
Han-Hsiun Chen
, Keng-Hao Chang
, et al.
·
Journal of Biomedical Science
PDF
Smyca-FOXM1 ribonucleoprotein complex promotes homologous recombination and tumor immune evasion to define a therapeutic target of triple-negative breast cancer
2026
·
Han-Hsiun Chen
, Keng-Hao Chang
, et al.
·
Figshare
Table S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Table S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Figure S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Data from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Data from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Figure S1 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Table S2 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Table S2 from Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy
2024
·
Te-An Lee
, En-Yun Tsai
, et al.
Abstract 4106: Non-autonomous enhancement of gPDL1 CAR-T annihilates TNBC development
2023
·
Chia-Wei Li
, Shih-Han Wang
, et al.
·
Cancer Research
Show more works
View as search
Works count:
16
Citation count:
80
H-index:
2
I10-index:
2
Year
Topic
Type